SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-038468
Filing Date
2023-06-20
Accepted
2023-06-20 17:00:16
Documents
1
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4411
  Complete submission text file 0001209191-23-038468.txt   5838
Mailing Address DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803
Business Address
ADELMAN BURT A (Reporting) CIK: 0001226283 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40489 | Film No.: 231026071

Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations